Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andreas Metzner , Erik Wissner , Tina Lin , et al Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1.5–2 % of the general population.1 In the current clinical guidelines, catheter ablation is recommended in addition to drug-based antiarrhythmic therapy for patients suffering from symptomatic, drugrefractory AF. However, catheter ablation, if performed at an experienced centre, may also serve as first-line therapy in… View more

Electrophysiology & Arrhythmia
Job title: Consultant Paediatric Cardiologist
Professor Shakeel Qureshiis a London based paediatric cardiologistwhose achievements include interventions incongenital heart disease. He carries out a variety of interventions inpaediatricandadult congenital cardiology, including ballooning of arteries and valves. He has developed innovative keyhole procedures as aconsultant paediatric cardiologistatGuy’s and St Thomas’ Hospital Trustand has… View more
Author(s): David Filgueiras-Rama , Jose L Merino Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained arrhythmia in the clinical practice.1 The prevalence of the arrhythmia is progressively increasing in developed countries and moreover, it is expected to affect up to 12 million people only in the US by 2050.2 Antiarrhythmic drugs continue to represent the first-line of treatment in AF patients, either to restore sinus rhythm or to prevent… View more

Electrophysiology & Arrhythmia
Author(s): Konstantinos C Siontis , Hakan Oral Added: 3 years ago
Advanced catheter-based technologies employed for the ablation of symptomatic atrial fibrillation (AF) have revolutionised the management of this common sustained arrhythmia. In the late 1990s, premature depolarisations originating from the myocardial sleeves within the pulmonary veins were recognised to initiate AF. This landmark discovery rendered pulmonary vein isolation (PVI) as the… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
Author(s): Fehmi Keçe , Katja Zeppenfeld , Serge A Trines Added: 3 years ago
Catheter ablation is an effective strategy to maintain sinus rhythm in patients with symptomatic atrial fibrillation (AF), which has evolved from a highly specialised technique to a first-line therapy.1–3 The cornerstone of ablation is pulmonary vein isolation (PVI).4 Over the last decade, ablation devices have undergone technical improvements, aiming for better lesion durability and ablation… View more

Electrophysiology & Arrhythmia
The Cutting Edge of Atrial Fibrillation Ablation
Author(s): Maya S Verma , Maria Terricabras , Atul Verma Added: 2 years ago

Electrophysiology & Arrhythmia
Session 8: New Technologies Here and on the Horizon
Added: 6 years ago

Electrophysiology & Arrhythmia
Author(s): Tina Lin , Feifan Ouyang , Karl-Heinz Kuck , et al Added: 3 years ago

Electrophysiology & Arrhythmia

Intervention
Author(s): Satoshi Higa , Li-Wei Lo , Shih-Ann Chen Added: 3 years ago
Catheter ablation of AF has become an established therapy and may have the potential to cure this most commonly encountered sustained arrhythmia. Previous studies have demonstrated that pulmonary veins (PVs) are a major source of the ectopic beats that initiate AF. PV isolation in patients with symptomatic paroxysmal AF refractory to antiarrhythmic drugs is effective; however, it is difficult to… View more

Electrophysiology & Arrhythmia